Needle in a haystack or elephant in the room? Identifying germline predisposition syndromes in the setting of a new myeloid malignancy diagnosis.

Autor: Reinig EF; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA., Rubinstein JD; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.; Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Patil AT; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA., Schussman AL; Department of Surgery, University of Wisconsin-Madison, Madison, WI, USA.; Center for Human Genomics and Precision Medicine, University of Wisconsin-Madison, Madison, WI, USA., Horner VL; Wisconsin State Laboratory of Hygiene, University of Wisconsin-Madison, Madison, WI, USA., Kanagal-Shamanna R; Department of Hematopathology and Molecular Diagnostics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Churpek JE; Division of Hematology, Medical Oncology, and Palliative Care, Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA.; Wisconsin Blood Cancer Research Institute, Madison, WI, USA., Matson DR; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA. drmatson@wisc.edu.; Wisconsin Blood Cancer Research Institute, Madison, WI, USA. drmatson@wisc.edu.

Publikováno v: Leukemia [Leukemia] 2023 Aug; Vol. 37 (8), pp. 1589-1599. Date of Electronic Publication: 2023 Jul 01.